LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 3 of total 3

Search options

  1. Article: Troponin in COVID-19: To Measure or Not to Measure? Insights from a Prospective Cohort Study.

    Moll-Bernardes, Renata / Mattos, João D / Schaustz, Eduardo B / Sousa, Andréa S / Ferreira, Juliana R / Tortelly, Mariana B / Pimentel, Adriana M L / Figueiredo, Ana Cristina B S / Noya-Rabelo, Marcia M / Sales, Allan R K / Albuquerque, Denilson C / Rosado-de-Castro, Paulo H / Camargo, Gabriel C / Souza, Olga F / Bozza, Fernando A / Medei, Emiliano / Luiz, Ronir R

    Journal of clinical medicine

    2022  Volume 11, Issue 19

    Abstract: Myocardial injury (MI), defined by troponin elevation, has been associated with increased mortality and adverse outcomes in patients with coronavirus disease 2019 (COVID-19), but the role of this biomarker as a risk predictor remains unclear. Data from ... ...

    Abstract Myocardial injury (MI), defined by troponin elevation, has been associated with increased mortality and adverse outcomes in patients with coronavirus disease 2019 (COVID-19), but the role of this biomarker as a risk predictor remains unclear. Data from adult patients hospitalized with COVID-19 were recorded prospectively. A multiple logistic regression model was used to quantify associations of all variables with in-hospital mortality, including the calculation of odds ratios (ORs) and confidence intervals (CI). Troponin measurement was performed in 1476 of 4628 included patients, and MI was detected in 353 patients, with a prevalence of 23.9%; [95% CI, 21.8-26.1%]. The total in-hospital mortality rate was 10.9% [95% CI, 9.8-12.0%]. The mortality was much higher among patients with MI than among those without MI, with a prevalence of 22.7% [95% CI, 18.5-27.3%] vs. 5.5% [95% CI, 4.3-7.0%] and increased with each troponin level. After adjustment for age and comorbidities, the model revealed that the mortality risk was greater for patients with MI [OR = 2.99; 95% CI, 2.06-4.36%], and for those who did not undergo troponin measurement [OR = 2.2; 95% CI, 1.62-2.97%], compared to those without MI. Our data support the role of troponin as an important risk predictor for these patients, capable of discriminating between those with a low or increased mortality rate. In addition, our findings suggest that this biomarker has a remarkable negative predictive value in COVID-19.
    Language English
    Publishing date 2022-10-09
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2662592-1
    ISSN 2077-0383
    ISSN 2077-0383
    DOI 10.3390/jcm11195951
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Impact of the immune profiles of hypertensive patients with and without obesity on COVID-19 severity.

    Moll-Bernardes, Renata / Ferreira, Juliana R / Sousa, Andréa Silvestre / Tortelly, Mariana B / Pimentel, Adriana L / Figueiredo, Ana Cristina B S / Schaustz, Eduardo B / Secco, José Carlos Pizzolante / Sales, Allan Robson Kluser / Terzi, Flavia V O / Xavier de Brito, Adriana / Sarmento, Renée O / Noya-Rabelo, Marcia M / Fortier, Sergio / Matos E Silva, Flavia A / Vera, Narendra / Conde, Luciana / Cabral-Castro, Mauro Jorge / Albuquerque, Denilson C /
    Rosado de-Castro, Paulo / Camargo, Gabriel C / Pinheiro, Martha V T / Souza, Olga F / Bozza, Fernando A / Luiz, Ronir R / Medei, Emiliano

    International journal of obesity (2005)

    2023  Volume 48, Issue 2, Page(s) 254–262

    Abstract: Background: Comorbidities such as obesity, hypertension, and diabetes are associated with COVID-19 development and severity, probably due to immune dysregulation; however, the mechanisms underlying these associations are not clear. The immune signatures ...

    Abstract Background: Comorbidities such as obesity, hypertension, and diabetes are associated with COVID-19 development and severity, probably due to immune dysregulation; however, the mechanisms underlying these associations are not clear. The immune signatures of hypertensive patients with obesity with COVID-19 may provide new insight into the mechanisms of immune dysregulation and progression to severe disease in these patients.
    Methods: Hypertensive patients were selected prospectively from a multicenter registry of adults hospitalized with COVID-19 and stratified according to obesity (BMI ≥ 30 kg/m²). Clinical data including baseline characteristics, complications, treatment, and 46 immune markers were compared between groups. Logistic regression was performed to identify variables associated with the risk of COVID-19 progression in each group.
    Results: The sample comprised 213 patients (89 with and 124 without obesity). The clinical profiles of patients with and without obesity differed, suggesting potential interactions with COVID-19 severity. Relative to patients without obesity, patients with obesity were younger and fewer had cardiac disease and myocardial injury. Patients with obesity had higher EGF, GCSF, GMCSF, interleukin (IL)-1ra, IL-5, IL-7, IL-8, IL-15, IL-1β, MCP 1, and VEGF levels, total lymphocyte counts, and CD8
    Conclusion: Our findings suggest that clinical and immune variables and obesity interact synergistically to increase the COVID-19 progression risk. The immune signatures of hypertensive patients with and without obesity severe COVID-19 highlight differences in immune dysregulation mechanisms, with potential therapeutic applications.
    MeSH term(s) Adult ; Humans ; CD8-Positive T-Lymphocytes ; COVID-19/complications ; COVID-19/metabolism ; Epidermal Growth Factor/metabolism ; Vascular Endothelial Growth Factor A ; HLA-DR Antigens/metabolism ; Hypertension/complications ; Hypertension/epidemiology ; Hypertension/metabolism ; Obesity/complications ; Obesity/metabolism ; Diabetes Mellitus
    Chemical Substances Epidermal Growth Factor (62229-50-9) ; Vascular Endothelial Growth Factor A ; HLA-DR Antigens
    Language English
    Publishing date 2023-11-06
    Publishing country England
    Document type Multicenter Study ; Journal Article
    ZDB-ID 752409-2
    ISSN 1476-5497 ; 0307-0565
    ISSN (online) 1476-5497
    ISSN 0307-0565
    DOI 10.1038/s41366-023-01407-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: New Insights on the Mechanisms of Myocardial Injury in Hypertensive Patients With COVID-19.

    Moll-Bernardes, Renata / Ferreira, Juliana R / Schaustz, Eduardo B / Sousa, Andréa S / Mattos, João D / Tortelly, Mariana B / Pimentel, Adriana L / Figueiredo, Ana Cristina B S / Noya-Rabelo, Marcia M / Fortier, Sergio / Matos E Silva, Flavia A / Vera, Narendra / Conde, Luciana / Cabral-Castro, Mauro Jorge / Albuquerque, Denilson C / Rosado-de-Castro, Paulo Henrique / Camargo, Gabriel C / Pinheiro, Martha V T / Freitas, Daniele O L /
    Pittella, Ana M / Araújo, José Afonso M / Marques, André C / Gouvêa, Elias P / Terzi, Flavia V O / Zukowski, Cleverson N / Gismondi, Ronaldo A O C / Bandeira, Bruno S / Oliveira, Renée S / Abufaiad, Barbara E J / Miranda, Jacqueline S S / Miranda, Luiz Guilherme / Souza, Olga F / Bozza, Fernando A / Luiz, Ronir R / Medei, Emiliano

    Journal of clinical immunology

    2023  Volume 43, Issue 7, Page(s) 1496–1505

    Abstract: Purpose: Myocardial injury is common in hypertensive patients with 2019 coronavirus disease (COVID-19). Immune dysregulation could be associated to cardiac injury in these patients, but the underlying mechanism has not been fully elucidated.: Methods!# ...

    Abstract Purpose: Myocardial injury is common in hypertensive patients with 2019 coronavirus disease (COVID-19). Immune dysregulation could be associated to cardiac injury in these patients, but the underlying mechanism has not been fully elucidated.
    Methods: All patients were selected prospectively from a multicenter registry of adults hospitalized with confirmed COVID-19. Cases had hypertension and myocardial injury, defined by troponin levels above the 99th percentile upper reference limit, and controls were hypertensive patients with no myocardial injury. Biomarkers and immune cell subsets were quantified and compared between the two groups. A multiple logistic regression model was used to analyze the associations of clinical and immune variables with myocardial injury.
    Results: The sample comprised 193 patients divided into two groups: 47 cases and 146 controls. Relative to controls, cases had lower total lymphocyte count, percentage of T lymphocytes, CD8
    Conclusion: Our findings suggest that lymphopenia, CD8
    MeSH term(s) Adult ; Humans ; CD8-Positive T-Lymphocytes ; ADP-ribosyl Cyclase 1 ; COVID-19/complications ; HLA-DR Antigens ; Biomarkers ; Lymphocyte Activation
    Chemical Substances ADP-ribosyl Cyclase 1 (EC 3.2.2.6) ; HLA-DR Antigens ; Biomarkers
    Language English
    Publishing date 2023-06-09
    Publishing country Netherlands
    Document type Multicenter Study ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 779361-3
    ISSN 1573-2592 ; 0271-9142
    ISSN (online) 1573-2592
    ISSN 0271-9142
    DOI 10.1007/s10875-023-01523-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top